key: cord-0685569-6lqrw3xq
authors: Caparros-Gonzalez, Rafael A.; Pérez-Morente, María Angeles; Hueso-Montoro, Cesar; Álvarez-Serrano, María Adelaida; de la Torre-Luque, Alejandro
title: Congenital, Intrapartum and Postnatal Maternal-Fetal-Neonatal SARS-CoV-2 Infections: A Narrative Review
date: 2020-11-20
journal: Nutrients
DOI: 10.3390/nu12113570
sha: ba211d65d86b7e730bfd83381f979895ee695667
doc_id: 685569
cord_uid: 6lqrw3xq

Background: There is inconclusive evidence regarding congenital, intrapartum, and postnatal maternal-fetal-neonatal SARS-CoV-2 infections during the COVID-19 pandemic. A narrative review was conducted with the aim of guiding clinicians on the management of pregnant women with respect to congenital, intrapartum, and postnatal maternal-fetal-neonatal SARS-CoV-2 infections and breastfeeding during the COVID-19 pandemic. Methods: Searches were conducted in Web of Science, PubMed, Scopus, Dialnet, CUIDEN, Scielo, and Virtual Health Library to identify observational, case series, case reports, and randomized controlled trial studies assessing the transmission of SARS-CoV-2 from mother to baby and/or through breastfeeding during the COVID-19 pandemic. Results: A total of 49 studies was included in this review, comprising 329 pregnant women and 331 neonates (two pregnant women delivered twins). The studies were performed in China (n = 26), USA (n = 7), Italy (n = 3), Iran (n = 2), Switzerland (n = 1), Spain (n = 1), Turkey (n = 1), Australia (n = 1), India (n = 1), Germany (n = 1), France (n = 1), Canada (n = 1), Honduras (n = 1), Brazil (n = 1), and Peru (n = 1). Samples from amniotic fluid, umbilical cord blood, placenta, cervical secretion, and breastmilk were collected and analyzed. A total of 15 placental swabs gave positive results for SARS-CoV-2 ribonucleic acid (RNA) on the fetal side of the placenta. SARS-CoV-2 RNA was found in seven breastmilk samples. One umbilical cord sample was positive for SARS-CoV-2. One amniotic fluid sample tested positive for SARS-CoV-2. Conclusions: This study presents some evidence to support the potential of congenital, intrapartum, and postnatal maternal-fetal-neonatal SARS-CoV-2 infections during the COVID-19 pandemic. Mothers should follow recommendations including wearing a facemask and hand washing before and after breastfeeding.

The new coronavirus disease has rapidly spread around the world since its first identification in Wuhan (China) [1] . COVID-19 is caused by a coronavirus named SARS-CoV-2 

A total of 302 studies was selected. The search on WOS provided 25 hits. The search on PubMed offered 162 outcomes, while 86 studies were found through SCOPUS. Twenty-nine results were identified through VHL. No studies were found on Dialnet, CUIDEN, or Scielo. See Figure 1 for a detailed view of the selection and inclusion process.

Forty-nine studies were included in this review after assessing their eligibility . All the studies (n = 49) selected in this review were case studies or case reports published in 2020. A pool of 329 pregnant women and their 331 neonates (two pregnant women delivered twins) was derived from the selected studies. Nevertheless, an overlap in cases might be present. The majority of studies were performed in China (n = 26), and the rest were performed in the USA (n = 7), Italy (n = 3), Iran (n = 2), Switzerland (n = 1), Spain (n = 1), Turkey (n = 1), Australia (n = 1), India (n = 1), Germany (n = 1), France (n = 1), Canada (n = 1), Honduras (n = 1), Brazil (n = 1), and Peru (n = 1).

Maternal-fetal-neonatal SARS-CoV-2 infection can occur in utero (following maternal viremia and placental infection), intrapartum (via cervical or vaginal secretions), or after birth via breast milk. The detection of the virus by polymerase chain reaction (PCR) in umbilical cord blood or neonatal blood collected within the first 12 h of birth or amniotic fluid collected prior to the rupture of the membrane gives evidence for a congenital infection [10] . A narrative synthesis is presented below. 

A total of 302 studies was selected. The search on WOS provided 25 hits. The search on PubMed offered 162 outcomes, while 86 studies were found through SCOPUS. Twenty-nine results were identified through VHL. No studies were found on Dialnet, CUIDEN, or Scielo. See Figure 1 for a detailed view of the selection and inclusion process.

Forty-nine studies were included in this review after assessing their eligibility . All the studies (n = 49) selected in this review were case studies or case reports published in 2020. A pool of 329 pregnant women and their 331 neonates (two pregnant women delivered twins) was derived from the selected studies. Nevertheless, an overlap in cases might be present. The majority of studies were performed in China (n = 26), and the rest were performed in the USA (n = 7), Italy (n = 3), Iran (n = 2), Switzerland (n = 1), Spain (n = 1), Turkey (n = 1), Australia (n = 1), India (n = 1), Germany (n = 1), France (n = 1), Canada (n = 1), Honduras (n = 1), Brazil (n = 1), and Peru (n = 1).

Maternal-fetal-neonatal SARS-CoV-2 infection can occur in utero (following maternal viremia and placental infection), intrapartum (via cervical or vaginal secretions), or after birth via breast milk. The detection of the virus by polymerase chain reaction (PCR) in umbilical cord blood or neonatal blood collected within the first 12 h of birth or amniotic fluid collected prior to the rupture of the membrane gives evidence for a congenital infection [10] . A narrative synthesis is presented below.

Amniotic fluid was assessed from pregnant women with a positive result for COVID-19 in 11 studies [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . Only one study reported a positive result for SARS-CoV-2 [20] . This study was a case report conducted in Iran on a 22-year-old woman who delivered a baby at 33 weeks of gestation through a C-section. Throat swab samples were obtained and analyzed from the neonate over several days. This neonate had a positive result for SARS-CoV-2 24 h after birth and a week later. The neonate had no severe symptoms. The mother in this study died due to respiratory complications [22] . No SARS-CoV-2 infection was found in the rest of studies that evaluated amniotic fluid [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] .

A total of 12 studies looked for SARS-CoV-2 infection in umbilical cord blood [11] [12] [13] [14] [15] [16] 18, 20, [23] [24] [25] [26] . In 10 studies, umbilical cord blood samples tested negative for SARS-CoV-2 [11] [12] [13] [14] 18, 22, 23, [27] [28] [29] . Two studies reported a positive result for SARS-CoV-2 RNA in umbilical cord samples [15, 26] . No blood sample was collected or assessed from the umbilical cord in one of these studies [26] . Instead, the positive result obtained for SARS-CoV-2 was reported to be from the umbilical cord stump [26] . According to the authors, the umbilical cord stump was collected observing strict aseptic precautions and following the Indian national guidelines at birth to minimize the contamination of samples. Both neonates in these studies had a negative result for SARS-CoV-2 [15, 26] .

Placental tissue was analyzed in 17 studies [12, [14] [15] [16] [17] 21, 25, 26, [29] [30] [31] [32] [33] [34] [35] [36] [37] . Although the placentas tested negative in six studies [12, 14, 16, 17, 30, 31] , a total of 16 placental swabs tested positive for SARS-CoV-2 RNA on the fetal side of the placenta [15, 21, 25, 26, 29, [32] [33] [34] [35] [36] [37] . SARS-CoV-2 RNA has been found to be present in the syncytiotrophoblast [34, [36] [37] [38] , cytotrophoblast [34] , chorionic villi endothelial cells, and in trophoblasts [35] among samples from pregnant women who tested positive for SARS-CoV-2. COVID-19 coronavirus RNA was found in the placenta of a PCR-negative pregnant woman. This woman had SARS-CoV-2 antibodies 10 days after birth [26] . Besides, five placental showed areas of inflammatory infiltrate and infarction [21, 25, 33, 36, 37] . Among those studies reporting a positive result for SARS-CoV-2 RNA in the placenta [15, 21, 25, 26, 29, [32] [33] [34] [35] [36] [37] , six neonates resulted positive for SARS-CoV-2 [21, 26, 29, 33, 36] .

Maternal cervical secretion was only assessed in three case report studies [14, 17, 21] . One study assessing maternal cervical secretion reported a positive test for SARS-CoV-2 [21] . The neonate in this study had a positive test for SARS-CoV-2 [21] .

SARS-CoV-2 RNA has been found in seven studies [33, [39] [40] [41] [42] [43] [44] . Using Real-Time Quantitative Reverse Transcription-PCR (qRT-PCR) for SARS-CoV-2 N and ORF1b-nsp14 genes for SARS-CoV-2 detection, SARS-CoV-2 RNA was found in human breast milk from both the right and left breast between 10-15 days after birth [39, 40] . SARS-CoV-2 RNA was detected in colostrum and breast milk by SARS-CoV-2 RT-PCR testing at 8, 72, and 96 h after birth [41] and even after storing a sample of breast milk at −80 • C for 30 days [42] . In this study, a preterm newborn was fed using SARS-CoV-2-positive breast milk. The preterm newborn nasopharyngeal swabs were negative for SARS-CoV-2 RNA [42] . An additional study reported a positive case for SARS-CoV-2 RNA in breast milk, but information on sample collection was not provided [33] . Two further studies found a positive result for SARS-CoV-2 Immunoglobulin G (IgG), but breast milk was negative for SARS-CoV-2 Immunoglobulin M (IgM) and SARS-CoV-2 RNA in the same sample [45, 46] . SARS-CoV-2 was not found in six studies analyzing breast milk samples [11] [12] [13] [14] 17, 27] .

In total, 321 neonates were fed with formula. Ten neonates in this review were breastfed while their mothers were wearing a mask [29, 33, 35, [39] [40] [41] [42] [43] [44] [45] . Although those mothers wore a mask to breastfeed their neonates, five neonates had a positive result for SARS-CoV-2 [33, [39] [40] [41] [42] .

The main results of the included studies are described in Table 1 . Table 1 displays information on the city and country where a certain study was performed, the study design, number of pregnant women participating in each study, maternal age, number of fetuses participating in each study, trimester of pregnancy when the COVID-19 diagnosis was performed, number of pregnant women having a positive test for SARS-CoV-2, gestational age at birth, neonates having a positive throat swab for SARS-CoV-2 (yes = 1; no = 0), potential and confirmed maternal source of neonatal SARS-CoV-2 infection, neonatal feeding method (breast milk versus formula), and number of vaginally born neonates. 

There is limited evidence on the detrimental impact that COVID-19 may have on pregnancy [1, 7] . Inconsistencies exist regarding congenital, intrapartum, and postnatal maternal-fetal-neonatal SARS-CoV-2 infections [8] . Although the benefits that breast milk can have on neonatal health have been reported [60] , women are recommended not to breastfeed their neonates during the COVID-19 pandemic [13, 16, 20, 21, 26, 27, 31, 47, 49, 55, 59] . The aim of this study was to gather the most up-to-date evidence on the congenital and intrapartum transmission of SARS-CoV-2 from mother-to-child and to extract integrated conclusions from the existing literature. Potential postnatal transmission through breast milk was also considered.

Studies included in this review were all case reports and case series assessing the congenital, intrapartum, and postnatal maternal-fetal-neonatal transmission of SARS-CoV-2. All pregnant women included in the studies had a positive throat swab test for SARS-CoV-2 infection.

Studies assessing amniotic fluid comprised of 10 studies. Most of the neonates among these 10 studies were delivered by C-section in a negative-pressure room [11] [12] [13] [14] [16] [17] [18] [19] [20] [21] . The amniotic fluid samples assessed in those studies were collected after the rupture of membranes in an operating room at the time of a C-section in eight studies [11, 12, 14, 16, [18] [19] [20] [21] . These studies reported and guaranteed that the amniotic fluid samples were not contaminated and represented fetal intrauterine conditions [11, 12, 14, 16, [18] [19] [20] [21] . The bulk of the studies reported a negative test for SARS-CoV-2 in amniotic fluid specimens. This finding is in line with previous studies concluding that the transmission of SARS-CoV-2 through amniotic fluid during the COVID-19 pandemic was unlikely to occur [1, 3] . Unfortunately, those studies were based on samples collected during the early stages of the COVID-19 outbreak [1, 3] . In the present review, one study reported a positive test for SARS-CoV-2 inflection in amniotic fluid from a pregnant woman [20] . Due to her severe health state, the pregnant woman in this case report had a C-section and a preterm neonate was born at 33 weeks of gestation. This neonate had a positive result for SARS-CoV-2 but with no respiratory distress. The neonate was fed with formula. Due to respiratory complications, the mother died 16 days after the C-section. An absence of viral RNA was determined from amniotic fluid specimens tested by reverse transcriptase-polymerase chain reaction (RT-PCR) among pregnant women who were positive for previous coronavirus diseases (SARS or MERS) [61] . The findings from studies assessing amniotic fluid suggest that the transmission of SARS-CoV-2 through the amniotic fluid is unlikely to occur. Only one study in this review informed of a positive result for SARS-CoV-2 in amniotic fluid [61] . This finding might have been due to the contamination of the amniotic fluid sample.

Ten studies assessing umbilical cord blood samples reported a negative result for SARS-CoV-2, including [11] [12] [13] [14] 16, 18, 20, [23] [24] [25] . Negative results for SARS-CoV-2 infection in cord blood have been previously reported [1, 3] . These findings support some studies that found no evidence of the viral shedding of SARS or MERS in umbilical cord blood [61] [62] [63] .

In this review, we included a single study reporting a positive result for SARS-CoV-2 in the umbilical stump from a neonate who tested positive for SARS-CoV-2 [26] . This same study reported a positive result for SARS-CoV-2 in the placenta [26] . Delayed cord clamping was not performed in this case study [26] . The mother's nasopharyngeal aspirate was negative for SARS-CoV-2 on the day of admission and at day five. However, the mother tested positive for antibodies 10 days after delivery [26] . None of the studies included in this review reported the presence of SARS-CoV-2 in umbilical cord blood [11] [12] [13] [14] 16, 18, 20, [23] [24] [25] .

Only one study found SARS-CoV-2 in the umbilical cord; this finding was gathered from the umbilical cord stump but not from umbilical cord blood [26] . This finding suggests that SARS-CoV-2 might not cross the placenta barrier through the umbilical cord. Extreme caution should be maintained when manipulating biological measures. It is recommended that protocols are strictly followed to obtain the most accurate results.

A total of 11 studies reported a positive test for SARS-CoV-2 RNA in placental tissues [21, 25, 26, 29, [32] [33] [34] [35] [36] [37] [38] . It has been reported that SARS-CoV-2 can bind to the angiotensin-converting enzyme 2 (ACE2) receptors in the placenta for cell entry [64] . The fact that SARS-CoV-2 may cross the placental barrier by means of binding to the ACE2 receptor supports the potential risk of the mother-to-infant transmission of SARS-CoV-2 [38] . A study in this review reported a second-trimester miscarriage in a pregnant woman who was positive for SARS-CoV-2 [25] . The miscarriage in this study appeared to be related to a placental infection with SARS-CoV-2. Nevertheless, fetal samples from the anus, liver, thymus, and lung tested negative for SARS-CoV-2 [25] . On the contrary, a previous study presented some evidence on the unlikelihood of SARS-CoV-2 infecting the placenta, despite ACE2 being minimally expressed in the placenta during pregnancy [65] . Certain viruses such as the Zika virus were found to evade the protection that the placenta barrier confers. Due to the effects that a congenital Zika infection can have, thousands of microcephalic neonates were reported in 2016 [66] . Six studies analyzing the placenta samples in this review gave a negative result for SARS-CoV-2 [12, 14, 16, 17, 30, 31] . These results are in line with studies on SARS that were unable to find coronavirus in placentas [60] [61] [62] . Although no SARS was found in some of the placenta specimens, these placentas were reported to present increased subchorionic, intervillous fibrin, thrombotic vasculopathy, and areas of avascular chorionic villi, which are associated with fetal vascular malperfusion and fetal intrauterine growth restriction [62] .

The fact that SARS-CoV-2 RNA has been found in placental tissues from 11 studies in this review [21, 25, 26, 29, [32] [33] [34] [35] [36] [37] [38] reflects the potential transmission of SARS-CoV-2 from mother to fetus. In fact, seven studies with a positive result for SARS-CoV-2 reported a neonatal positive throat swab for SARS-CoV-2 [21, 25, 26, 29, 34, 36, 37] . Although the placenta may play a key role in protecting fetuses against a SARS-CoV-2 infection [65] , this might not be always the case.

The United Nations Children's Fund has asserted that breastfeeding provides neonates with a range of micronutrients that may protect them against infections [67] . The WHO has stated that every neonate in the world should be breastfed for at least 6 months [68] . However, only eight studies included in this review reported that neonates were breastfed [29, 33, 35, [39] [40] [41] [42] 45] . Breast milk samples had a positive result for SARS-CoV-2 infection in seven studies that evaluated human milk from mothers infected with the same virus [33, [39] [40] [41] [42] [43] [44] Five studies in this review reported a positive neonatal case for SARS-CoV-2 among mothers with a positive result for SARS-CoV-2 in breast milk [33, [39] [40] [41] [42] . It should be clarified whether those neonates were positive for SARS-CoV-2 before or after they were breastfed. Future studies should take into consideration the potential contamination of breast milk from neonates' saliva while breastfeeding. None of the studies in this review attempted to culture the SARS-CoV-2 from breast milk samples. Although SARS-CoV-2 RNA has been isolated from breast milk samples, it is still unclear whether breast milk has a potential infectious capacity [69] .

Additionally, two studies reported the presence of SARS-CoV-2 IgG in breast milk samples from SARS-CoV-2 positive mothers [45, 46] . SARS-CoV-2 IgG was only identified very early after birth (up to 1.5 months later) [46] . Due to the presence of SARS-CoV-2 IgG in two studies, the potential protective role of breast milk against SARS-CoV-2 should be considered [45, 46] . The Chinese expert consensus group for managing mothers and neonates with COVID-19 announced that breastfeeding is not recommended [69] . According to the articles reviewed, there is some probability that SARS-CoV-2 infection can be transmitted through breast milk. Due to the SARS-CoV-2 virus being transmitted through respiratory droplets during breastfeeding [4, 70] , certain recommendations should be taken into consideration if an infected mother decides to breastfeed her neonate. These recommendations have been provided by the Center for Disease Control and Prevention and include wearing a facemask and hand washing before and after breastfeeding [71] . Besides, it has been reported that holder pasteurization, but not freezing, can inactivate the SARS-CoV-2 virus [72] .

In summary, in this review, some studies reported that SARS-CoV-2 RNA was found in amniotic fluid, placenta, umbilical cord, and breast milk. Besides, it was found in this review that mothers transmitted SARS-CoV-2 to some neonates through amniotic fluid (n = 1 neonate), cervical secretion (n = 1), placenta (n = 6 neonates), breast milk (n = 5 neonates). Findings from this review support the transplacental infection of COVID-19 in certain cases. Nevertheless, it is not yet clear that SARS-CoV-2 can always be transmitted from mother to infant. Future studies assessing the potential transmission of SARS-CoV-2 from mother to infant should clarify this issue. Prospective studies should also address the circumstances that facilitate or prevent SARS-CoV-2 from crossing the placenta barrier.

Limitations of this study include the fact that all the studies included were case reports or case series. An overlapping of participants among studies might be present. Some studies in this review did not perform analyses for amniotic fluid, cord blood, placenta, or breast milk. Future studies should test as many samples as possible in order to find potential sources of transmission of SARS-CoV-2 from mother to child, especially in those cases in which both the mother and the child had a positive test for SARS-CoV-2. 

Eating Habits and Physical Activity of the Spanish Population during the COVID-19 Pandemic Period

Responding to Community Spread of COVID-19: Interim Guidance

Maternal and neonatal consequences of coronavirus COVID-19 infection during pregnancy: A scoping review

Coronavirus Disease 2019 (COVID-19) and pregnancy: What obstetricians need to know

Coronavirus disease 2019 (COVID-19) and pregnancy: A systematic review

Care of newborns born to mothers with COVID-19 infection; a review of existing evidence

Emotional Eating in Pregnant Women during the COVID-19 Pandemic and Its Association with Dietary Intake and Gestational Weight Gain

Experience of Clinical Management for Pregnant Women and Newborns with Novel Coronavirus Pneumonia in Tongji Hospital

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

Classification system and case definition for SARS-CoV-2 infection in pregnant women, fetuses, and neonates

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records

Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2

Clinical characteristics of 19 neonates born to mothers with COVID-19. Front

Unlikely SARS-CoV-2 vertical transmission from mother to child: A case report

Intrauterine Transmission of SARS-CoV-2

A Case of 2019 Novel Coronavirus in a Pregnant Woman with Preterm Delivery

Vaginal delivery report of a healthy neonate born to a convalescent mother with COVID-19

Clinical characteristics and risk assessment of newborns born to mothers with COVID-19

SARS-CoV-2 detected in amniotic fluid in mid-pregnancy

Preterm delivery in pregnant woman with critical COVID-19 pneumonia and vertical transmission

Transplacental transmission of SARS-CoV-2 infection

A pregnant woman with COVID-19 in Central America

Impact of COVID-19 infection on pregnancy outcomes and the risk of maternal-to-neonatal intrapartum transmission of COVID-19 during natural birth

Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: A retrospective, single-centre, descriptive study

Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 Infection

Early-onset symptomatic neonatal COVID-19 infection with high probability of vertical transmission

Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019

Vertical transmission of coronavirus disease 2019: Severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019-positive mothers and neonates at birth

Pregnancy with new coronavirus infection: A clinical characteristics and placental pathological analysis of three cases

Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia

Detection of severe acute respiratory syndrome coronavirus 2 in placental and fetal membrane samples

Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection

SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: A series of 19 placentas from COVID-19-positive mothers

Placental SARS-CoV-2 in a Pregnant Woman with Mild COVID-19 Disease

SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta

SARS-CoV-2 infection of the placenta

Visualization of severe acute respiratory syndrome coronavirus 2 invading the human placenta using electron microscopy

Detection of SARS-CoV-2 in Human Breast Milk

Detectable Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Human Breast Milk of a Mildly Symptomatic Patient With Coronavirus Disease 2019 (COVID-19)

Virolactia in an Asymptomatic Mother with COVID-19

An Uninfected Preterm Newborn Inadvertently Fed SARS-CoV-2-Positive Breast Milk

Evaluation for SARS-CoV-2 in Breast Milk from 18 Infected Women

Breastfeeding Risk from Detectable Severe Acute Respiratory Syndrome Coronavirus 2 in Breastmilk

Breastfed 13 month-old infant of a mother with COVID-19 pneumonia: A case report

Antibodies in the breast milk of a maternal woman with COVID-19

Severe COVID-19 during Pregnancy and Possible Vertical Transmission

Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals

Infants Born to Mothers With a New Coronavirus (COVID-19). Front

Pronóstico perinatal y de la paciente embarazada con infección por COVID-19

WITHDRAWN: Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings

Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: A case-control study 2020

Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis

Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy

Asymptomatic COVID-19 infection in late pregnancy indicated no vertical transmission

Clinical Manifestation and Laboratory Characteristics of SARS-CoV-2 Infection in Pregnant Women

Radiological findings and clinical characteristics of pregnant women with COVID -19 pneumonia

Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province

Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia

Maternal and Neonatal Hair Cortisol Levels and Psychological Stress Are Associated With Onset of Secretory Activation of Human Milk Production

Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Does the human placenta express the canonical cell entry mediators for SARS-CoV-2? eLife 2020

Teratogenic effects of the Zika virus and the role of the placenta

The United Nations Children's Fund

World Health Organization; UNICEF. Planning Guide for National Implementation of the Global Strategy for Infant and Young Child Feeding

Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection

Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review

Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases. Interim Infection Prevention and Control Recommendations for Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) or Patients under Investigation for 2019-nCoV in Healthcare Settings. Pregnancy and Breastfeeding

SARS-CoV-2 in human milk is inactivated by Holder pasteurisation but not cold storage

The authors would like to thank all those clinicians that are taking care of the entire global population during this pandemic. Special thanks to obstetricians and midwives who have been looking after pregnant women and forthcoming generations.

The authors hold sole responsibility for the views expressed in the manuscript. The authors declare no conflict of interest.